Epimedium brevicornu (Epimedium brevicornu): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Epimedium brevicornu work in the body?

Epimedium brevicornu contains icariin, a prenylated flavonoid that acts as a PDE5 inhibitor, similar to sildenafil. This mechanism increases nitric oxide levels and improves blood flow. Icariin also modulates estrogen receptors and may influence testosterone pathways. The herb's flavonoids, including epimedins A-C and sagittatoside, contribute to its anti-inflammatory and bone-protective effects through osteoblast stimulation. Evidence Level: C.

Does Epimedium brevicornu interact with any medications?

Epimedium brevicornu may interact with blood thinners like warfarin due to potential effects on platelet aggregation. It should not be combined with PDE5 inhibitor medications (sildenafil, tadalafil) as this could cause excessive blood pressure drops. Those taking hormone therapies or medications for hormone-sensitive conditions should avoid this herb. Always consult a healthcare provider before combining with prescription medications. Evidence Level: C.

What is the recommended dosage for Epimedium brevicornu?

The typical adult dosage for Epimedium brevicornu is 500mg of encapsulated herb taken twice daily. Standardized extracts focusing on icariin content are also available and may offer more consistent potency. Dosage should be adjusted based on individual response and formulation strength. Consult a qualified practitioner for personalized dosing recommendations, especially if treating specific conditions like osteoporosis or sexual dysfunction. Evidence Level: Traditional.

Is Epimedium brevicornu safe during pregnancy and breastfeeding?

Epimedium brevicornu is contraindicated during pregnancy and breastfeeding. The herb's hormone-modulating effects, particularly its estrogenic activity, could potentially harm fetal development or affect nursing infants. Women with hormone-sensitive conditions such as breast cancer, endometriosis, or uterine fibroids should also avoid this herb. Discontinue use at least two weeks before scheduled surgery due to potential bleeding risks. Evidence Level: C.

Can Epimedium brevicornu help with bone density and osteoporosis?

Epimedium brevicornu has shown promise in supporting bone health through icariin's ability to stimulate osteoblast activity and inhibit bone resorption. Traditional Chinese Medicine has long used this herb for strengthening bones. Preliminary research suggests potential benefits for osteoporosis, though clinical evidence remains limited. This herb should complement, not replace, conventional osteoporosis treatments. Evidence Level: C.

What are the side effects of taking Epimedium brevicornu?

Common side effects of Epimedium brevicornu may include mild gastrointestinal upset, dry mouth, and dizziness. At higher doses, some users report tachycardia (rapid heartbeat) and restlessness due to the herb's stimulant properties. Hormone-related effects may occur, including changes in menstrual cycles. Those with cardiovascular conditions should use caution. Discontinue use if experiencing palpitations or severe symptoms. Evidence Level: C.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Epimedium brevicornu Maxim. is a traditional Chinese medicinal herb used for treating osteoporosis, sexual dysfunction, and various chronic illnesses [PMID:36386137, 37521477, 40873547].

Background

Epimedium brevicornu Maxim. (also known as Yin Yang Huo) is a perennial persistent C3 plant in the Berberidaceae family, widely distributed in South China and the Loess Plateau [PMID:33366141, 39112934, 40589949].

Traditional uses

It is traditionally used as a tonic, aphrodisiac, and anti-rheumatic agent, specifically for nourishing the kidneys, tonifying kidney-Yang, and improving sexual dysfunction [PMID:27445824, 40403897, 37521477].

Active compounds

Major bioactive constituents include prenyl-flavonoids such as icariin (the primary active ingredient), icaritin, icariside I, icariside II, wushanicaritin, and kumatakenin [PMID:21215308, 40403897, 38999560, 27445824]. It also contains polysaccharides, including a neutral homogeneous glucan (EPSN-1) [PMID:38858029].

Mechanism of action

Mechanisms include the stimulation of VEGF-mediated angiogenesis to alleviate osteoporosis [PMID:40992067], reduction of neuroinflammation via the cGAS-STING pathway [PMID:40403897], and activation of natural killer (NK) cells against hepatocellular carcinoma via the cGAS-STING pathway [PMID:41357886]. It may also inhibit osteoclast autophagy by degrading miRNA-199 to regulate the mTOR signaling pathway [PMID:40635043] and ameliorate osteoporosis through the NLRP3/caspase-1/IL-1β signaling pathway and the gut-bone axis [PMID:38897131].

Clinical evidence

Evidence DPostmenopausal Osteoporosis

Extracellular vesicle-like particles (EP-EVLPs) stimulate VEGF-mediated angiogenesis to alleviate the condition [PMID:40992067]; decoctions increase IGF-1 levels and reduce serum CTX-I levels [PMID:38897131].

Evidence DAlzheimer's Disease / Cognitive Dysfunction

Icariin improves memory impairment, alleviates neuronal damage and apoptosis, and suppresses neuroinflammation via the cGAS-STING pathway [PMID:40403897]; Icariside II promotes hippocampal neurogenesis by alleviating mitochondrial dysfunction [PMID:40351431].

Evidence DHepatocellular Carcinoma

Extract activates natural killer (NK) cells to exert anti-tumor effects [PMID:41357886].

Evidence DKidney-Yang Deficiency Syndrome (KDS)

Prepared folium (PFEB) is effective in increasing cAMP/cGMP ratio, testosterone levels, and improving sexual characteristics in mouse models [PMID:37521477, 38744386].

Evidence DColorectal Cancer

Icariin suppresses cell proliferation, migration, and invasion by inhibiting M2 macrophage polarization via the PI3K/AKT pathway [PMID:40683071].

Safety & adverse effects

Some studies indicate that Epimedii Folium could induce idiosyncratic drug-induced liver injury (IDILI), potentially involving the activation of the NLRP3 inflammasome by constituents like epimedin B [PMID:36386137].

Evidence summary

The current evidence is primarily based on in vitro studies and animal models (Level D), with some systematic reviews (Level A) and clinical mentions of traditional use (Level C).

PubMed sources

1.PMID: 40992067 (2025) — Epimedium brevicornu Maxim.-derived extracellular vesicle-like particles stimulate VEGF-mediated angiogenesis to alleviate postmenopausal osteoporosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
2.PMID: 40403897 (2025) — Icariin alleviates cognitive dysfunction by reducing neuroinflammation via the cGAS-STING pathway. · Journal of ethnopharmacology
3.PMID: 41357886 (2025) — Epimedium brevicornu Maxim. extract activates natural killer cells against hepatocellular carcinoma via the cGAS-STING pathway. · Frontiers in pharmacology
4.PMID: 36775079 (2023) — Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals. · Journal of ethnopharmacology
5.PMID: 37029621 (2024)

Epimedium brevicornu

Sources & Citations

Calculate a safe dose of Epimedium brevicornu